Vaccine researcher lays head on the block: "If Pfizer's Covid-19 vaccine works, so will ours"

On Monday, Pfizer and its partner Biontech announced promising results with potential vaccine for Covid-19 aimed at the same protein on which Bavarian Nordic and the vaccine firm Adaptvac are collaborating. The latter is jubilant, having no doubt that the Danish vaccine will work, if Pfizer's does.

Photo: Christian Brasen

Vaccine researchers at the biotech firms Bavarian Nordic and Adaptvac are on the right track with their potential vaccine for Covid-19 and a Danish vaccine will most likely enter the market in spring next year.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs